[ Price : $8.95]
FDA hosts a public meeting next month aimed at exploring ways to expand access to nonprescription medications.[ Price : $8.95]
U.S. Senator Rick Scott (R-FL) urges FDA and other federal health agencies to review and tighten oversight of clinical trials and ...[ Price : $8.95]
FDA approves Bristol Myers Squibbs Opdivo (nivolumab) for use with doxorubicin, vinblastine, and dacarbazine for adult and pediatr...[ Price : $8.95]
FDA is announcing a 6/12 public hearing to gather input on its Commissioners National Priority Voucher Pilot Program.[ Price : $8.95]
Lilly says its investigational type 2 diabetes triple agonist retatrutide met its key primary and secondary endpoints in a Phase 3...[ Price : $8.95]
Two Mintz attorneys say a CDRH Warning Letter to a medical device sponsor of clinical research and compassionate use protocols may...[ Price : $8.95]
FDA approves GSKs Lynavoy (linerixibat), the first U.S.-authorized therapy specifically for cholestatic pruritus in patients with ...[ Price : $8.95]
Sarepta says it will submit to FDA by the end of April sNDAs to convert the accelerated approvals of its Amondys 45 and Vyondys 53...